Medical Researchers: Aspirin May Lower Risk of Breast Cancer
医学研究者：阿斯匹林可降低乳腺癌发生风险

☆ aspirin 阿斯匹林(解热镇痛药)
     Breast Cancer 乳腺癌

声明：本文为VOA新闻，由于出不去，故以此代替，请大家谅解，在论坛中附了语音，需要者可去下。

欢迎到论坛发表评论：
 http://bbs.wwenglish.org/dispbbs.asp?boardid=108&id=103343

Barry Newhouse

Medical researchers say a new study shows women who regularly take aspirin may lower their risk of developing the most common type of breast cancer.
医学研究者声称：新的研究显示，定期服用阿斯匹林，可降低女性发生常见乳癌的风险。

Cancer researchers say a study of nearly 3000 women in New York found those who regularly took aspirin had a lower incidence of breast cancer than those who did not take aspirin.
癌症研究人员称，一项开展于纽约，涉及了近3000名妇女的研究表明，定期服用阿斯匹林的妇女乳癌发生率低于不服药者。

☆ incidence of breast cancer  乳腺癌发病率

Dr. Alfred Neugut is professor of medicine at Columbia University and one of the study's researchers. "Taking an aspirin a day, presumably reduces your risk of getting breast cancer by roughly 25 percent and that the specific type of breast cancer that's prevented is what one might characterize as estrogen-dependent breast cancer."
研究者之一，哥伦比亚大学医学博士Alfred Neugut称：“每天一颗阿斯匹林，可能使雌激素依赖性乳腺癌的病率降低大约25%。”

☆ estrogen 雌激素

Dr. Neugut said that aspirin appears to suppress the production of the hormone estrogen in the breast. Estrogen is partly responsible for causing the type of breast cancer that accounts for about 70 percent of all breast cancer cases.
Neugut博士说，阿斯匹林可抑制乳房中雌激素的产生。雌激素是常见型乳腺癌的重要诱发因素，该型乳腺癌约占全部乳腺癌病例的70%。

About one in eight American women develop breast cancer during her lifetime.
在美国，大约8个妇女中有1个罹患乳腺癌。

☆ lifetime 一生

Doctors say the study's findings do not mean that women should begin regularly taking aspirin, because more research is needed on the potential side effects of the drug. However, women who currently take aspirin for other medical conditions may also be lowering their risk of breast cancer.

Researcher Andrew Dannenberg says the study is also significant because it marks an important milestone in understanding and preventing cancer.

"In cardiology we know that using drugs such as anti-hypertensive agents protects against coronary artery disease. Oncology is probably 15 to 20 years behind, but this study represents a critical point because it illustrates preventing cancer as opposed to simply waiting to develop cancer."

The study's findings are published in the May 26 issue of The Journal of the American Medical Association.